<ul><li>Neuralink plans to implant its Blindsight brain-to-computer interface (BCI) device in a human patient by late 2025 or early 2026, focusing on restoring vision for individuals, including those born blind.</li><li>Elon Musk mentioned that Neuralink's first two human applications will be restoring vision, with confidence that individuals who have never had vision, even if they were born blind, could potentially see through the Blindsight technology.</li><li>Neuralink will partner with the Cleveland Clinic Abu Dhabi to conduct the first human trial of the UAE-PRIME study, aiming to help patients with motor and speech impairments.</li><li>Neuralink's Patient Registry is now open globally, with ongoing studies in the United States like PRIME and CONVOY focusing on restoring motor and speech capabilities using the Link implant technology.</li></ul>

Neuralink Blindsight human trials expected to start in the UAE

Discover more